ALX Oncology
ALXO
ALXO
85 hedge funds and large institutions have $22.1M invested in ALX Oncology in 2025 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 26 increasing their positions, 30 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
13% less repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 30
58% less call options, than puts
Call options by funds: $24K | Put options by funds: $57K
68% less capital invested
Capital invested by funds: $69M → $22.1M (-$46.8M)
Holders
85
Holding in Top 10
1
Calls
$24K
Puts
$57K
Top Buyers
| 1 | +$259K | |
| 2 | +$168K | |
| 3 | +$116K | |
| 4 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$85.4K |
| 5 |
AC
Almitas Capital
Santa Monica,
California
|
+$81.1K |
Top Sellers
| 1 | -$1.33M | |
| 2 | -$1.14M | |
| 3 | -$738K | |
| 4 |
MB
MPM BioImpact
Boston,
Massachusetts
|
-$524K |
| 5 |
DP
Diadema Partners
Morristown,
New Jersey
|
-$330K |
